SearchDictionaryMobileLogin

MAC conditioning regimen

Subscribe to Selected New Research on MAC conditioning regimen
1  relevant articles (0 outcomes, 0 trials/studies) found for this Bio-Agent

Description: a chemotherapy protocol consisting of the above compounds; used as a conditioning regimen for autologous bone marrow transplantation for acute leukemia

Bio-Agent Context: Research Results

-
Therapeutics: 6127
-
Drug Therapy: 124082
-
Combination Drug Therapy: 8615
-
Antineoplastic Combined Chemotherapy Protocols: 18
*
MAC conditioning regimen: 1
-
Antineoplastic Protocols: 20
-
Antineoplastic Combined Chemotherapy Protocols: 18
*
MAC conditioning regimen: 1
-
Clinical Protocols
-
Antineoplastic Protocols: 20
-
Antineoplastic Combined Chemotherapy Protocols: 18
*
MAC conditioning regimen: 1
-
Organic Chemicals: 42
-
Hydrocarbons: 362
-
Halogenated Hydrocarbons: 31
-
Mustard Compounds: 3
-
Nitrogen Mustard Compounds: 1
-
Melphalan: 2640
*
MAC conditioning regimen: 1
-
Phosphoramide Mustards: 3
-
Cyclophosphamide: 15509
*
MAC conditioning regimen: 1
-
Organophosphorus Compounds: 131
-
Phosphoramide Mustards: 3
-
Cyclophosphamide: 15509
*
MAC conditioning regimen: 1
-
Heterocyclic Compounds: 25
-
1-Ring Heterocyclic Compounds
-
Pyrimidines: 281
-
Pyrimidine Nucleosides: 38
-
Cytidine: 284
-
Cytarabine: 4307
*
MAC conditioning regimen: 1
-
Nucleic Acids, Nucleotides, and Nucleosides: 1
-
Nucleosides: 612
-
Pyrimidine Nucleosides: 38
-
Cytidine: 284
-
Cytarabine: 4307
*
MAC conditioning regimen: 1
-
Arabinonucleosides
-
Cytarabine: 4307
*
MAC conditioning regimen: 1
-
Amino Acids, Peptides, and Proteins
-
Amino Acids: 8786
-
Cyclic Amino Acids: 2
-
Aromatic Amino Acids: 234
-
Phenylalanine: 2166
-
Melphalan: 2640
*
MAC conditioning regimen: 1

Related Diseases

1. Leukemia

Related Therapies and Procedures

1. Bone Marrow Transplantation (Transplantation, Bone Marrow)

Best Treatments:
Research Summary Report
on Leukemia

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.
  • Free Updates for 1 Year
  • All 1827 Outcomes
  • Top 200 Key Drugs and Biologics
  • Top 50 Key Therapies and Procedures
  • Detailed History Charts
  • Full Research Reference Details
  • Sample PDF Report on Psoriasis >>
Price:$24.00 & Delivery via PDF download
updates for 1 year
Research Interface

 

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.
  • Unlimited Disease, Drug and Therapy Search
  • 2 clicks from Disease to Drug to Evidence
  • Trial References
  • All the Positive Outcomes
  • Detailed Relationship Timeline Charts
  • Full Article Reference Details
  • Includes Mobile Interface Subscription
  • One-click to FDA Products/Patents
  • Request Institution License Details >>
Price:$490.00 access via web interface
1 year subscription
Proceed to Checkout >>
Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.
  • Access from any web enabled PDA or Phone
  • Trial references
  • All the Positive Outcomes
  • Drug and Therapy searches
  • Full Article Reference Details
  • Try Mobile Interface >>
Price:$45.00 access via "curehunter.com/m"
1 year subscription
Proceed to Checkout >>